Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis. (2018)

First Author: Holroyd CR
Attributed to:  Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 29352847

Publication URI: http://europepmc.org/abstract/MED/29352847

Type: Journal Article/Review

Volume: 36

Parent Publication: Clinical and experimental rheumatology

Issue: 1

ISSN: 0392-856X